Literature DB >> 24185587

Incidence of and risk factors for persistent gram-positive bacteraemia and catheter-related thrombosis in haematopoietic stem cell transplantation.

A Richters1, M van Vliet1, P G M Peer2, P E Verweij3, B A P Laros-van Gorkom1, N M A Blijlevens4, J P Donnelly4, W J F M van der Velden4.   

Abstract

A cohort of 439 haematopoietic SCT recipients was analysed to determine the incidence of Gram-positive coccal bacteraemia and thromboembolic events associated with the use of central venous catheters (CVCs) and to determine risk factors for these complications. The incidences of persistent coagulase-negative staphylococcal (CoNS) bacteraemia, symptomatic thrombosis and thrombophlebitis were 25%, 9.6% and 6.6%, respectively. Duration of neutropenia (in days, odds ratio (OR) 1.02; P=0.04) and left-sided placement of the CVCs (OR 1.73; P=0.03) were independent risk factors for the occurrence of persistent CoNS bacteraemia, whereas the use of less mucotoxic conditioning regimens was associated with a lower risk (high-dose melphalan (HDM)/BEAM vs other regimens, OR 0.24; P<0.001). Use of TBI, persistent CoNS bacteraemia and tip colonisation were all significantly associated with an increased risk of symptomatic thrombosis (OR 6.03, 3.36 and 2.80, respectively; P0.02). The risk factors found in this cohort of SCT recipients differed from those found in the general cancer population, showing an important role for persisting bacteraemia in the pathogenesis of CVC-associated thrombosis. Therefore, we constructed a new algorithm in order to improve catheter management and prevent these CVC-related complications.

Entities:  

Mesh:

Year:  2013        PMID: 24185587     DOI: 10.1038/bmt.2013.172

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  29 in total

1.  Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies.

Authors:  W Saber; T Moua; E C Williams; M Verso; G Agnelli; S Couban; A Young; M De Cicco; R Biffi; C J van Rooden; M V Huisman; D Fagnani; C Cimminiello; M Moia; M Magagnoli; S P Povoski; S F Malak; A Y Lee
Journal:  J Thromb Haemost       Date:  2011-02       Impact factor: 5.824

2.  Leukocyte count and risk of thrombosis in patients undergoing haematopoietic stem cell transplantation or intensive chemotherapy.

Authors:  Nadina Stoffel; Christine Rysler; Andreas Buser; Alois Gratwohl; Dimitrios A Tsakiris; Martin Stern
Journal:  Thromb Haemost       Date:  2010-03-29       Impact factor: 5.249

3.  Guidelines for the prevention of intravascular catheter-related infections.

Authors:  Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint
Journal:  Am J Infect Control       Date:  2011-05       Impact factor: 2.918

4.  Colonization and molecular epidemiology of coagulase-negative Staphylococcal bacteremia in cancer patients: a pilot study.

Authors:  Silvia F Costa; Antonio A Barone; Marisa H Miceli; Inneke M van der Heijden; Robson E Soares; Anna S Levin; Elias J Anaissie
Journal:  Am J Infect Control       Date:  2006-02       Impact factor: 2.918

5.  The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population.

Authors:  Kedar S Deshpande; Carlo Hatem; Harry L Ulrich; Brian P Currie; Thomas K Aldrich; Christopher W Bryan-Brown; Vladimir Kvetan
Journal:  Crit Care Med       Date:  2005-01       Impact factor: 7.598

6.  Endocarditis complicating central venous catheter bloodstream infections: a unique form of health care associated endocarditis.

Authors:  Michael P Chrissoheris; Claudia Libertin; Ronan G Ali; Andre Ghantous; Amenuve Bekui; Thomas Donohue
Journal:  Clin Cardiol       Date:  2009-12       Impact factor: 2.882

7.  Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial.

Authors:  Lennert Slobbe; Jeanette K Doorduijn; Pieternella J Lugtenburg; Abdelilah El Barzouhi; Eric Boersma; Willem B van Leeuwen; Bart J A Rijnders
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

8.  The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention.

Authors:  David E Gerber; Jodi B Segal; M Yair Levy; Joyce Kane; Richard J Jones; Michael B Streiff
Journal:  Blood       Date:  2008-05-14       Impact factor: 22.113

9.  Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound.

Authors:  Cornelis J van Rooden; Frits R Rosendaal; Renée M Y Barge; Jacques A van Oostayen; Felix J M van der Meer; A Edo Meinders; Menno V Huisman
Journal:  Br J Haematol       Date:  2003-11       Impact factor: 6.998

10.  Coagulation on endothelial cells: the underexposed part of Virchow's Triad.

Authors:  Irma L A Geenen; Mark J Post; Daniel G M Molin; Geert W H Schurink; Jos G Maessen; Rene van Oerle; Hugo ten Cate; Henri M H Spronk
Journal:  Thromb Haemost       Date:  2012-09-05       Impact factor: 5.249

View more
  5 in total

1.  Central venous catheter-related thrombosis in senile male patients: New risk factors and predictors.

Authors:  Gao Liu; Zhi-Qing Fu; Ping Zhu; Shi-Jun Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

Review 2.  A systematic review of patient-related risk factors for catheter-related thrombosis.

Authors:  Amy Leung; Clare Heal; Marlon Perera; Casper Pretorius
Journal:  J Thromb Thrombolysis       Date:  2015-10       Impact factor: 2.300

Review 3.  Update on infection control practices in cancer hospitals.

Authors:  Ella J Ariza-Heredia; Roy F Chemaly
Journal:  CA Cancer J Clin       Date:  2018-07-09       Impact factor: 508.702

4.  Evaluation of central venous catheters coated with a noble metal alloy-A randomized clinical pilot study of coating durability, performance and tolerability.

Authors:  Gunilla Björling; Dorota Johansson; Linda Bergström; Anton Strekalovsky; Javier Sanchez; Claes Frostell; Sigridur Kalman
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2017-11-06       Impact factor: 3.368

5.  Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  Boris Böll; Enrico Schalk; Dieter Buchheidt; Justin Hasenkamp; Michael Kiehl; Til Ramon Kiderlen; Matthias Kochanek; Michael Koldehoff; Philippe Kostrewa; Annika Y Claßen; Sibylle C Mellinghoff; Bernd Metzner; Olaf Penack; Markus Ruhnke; Maria J G T Vehreschild; Florian Weissinger; Hans-Heinrich Wolf; Meinolf Karthaus; Marcus Hentrich
Journal:  Ann Hematol       Date:  2020-09-30       Impact factor: 3.673

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.